+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report by Type (HSV-1, HSV-2), Drug (Acyclovir, Valacyclovir, Famciclovir), Vaccine (Simplirix, Others), Route of Administration, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 80 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 5936582
Description Jump to:
The global herpes simplex virus treatment market is expected to reach USD 4.08 billion by 2030., expanding at a CAGR of 8.1% from 2024 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market.

According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs.

Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans.

Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth.

Herpes Simplex Virus Treatment Market Report Highlights

  • By treatment, the HSV-1 segment held the largest share in 2023 owing to the high prevalence of infection
  • By drug, the acyclovir segment is expected to grow at the fastest rate during the forecast period due to the effectiveness and availability of acyclovir as an oral and topical formulation
  • By vaccine, the simplirix segment is expected to grow at the fastest rate during the forecast period as it is the only vaccine available showing promising results as a vaccine candidate
  • North America dominated the global market in 2023 owing to the increasing awareness regarding STDs and the rise in healthcare expenditure


This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Herpes Simplex Virus Treatment Market: Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecasts timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis (model 2)
1.6.2.1 Approach 2: Volume price analysis
1.6.2.2 Revenue modeling
1.7 List of Secondary Sources
1.8 List of Primary Sources
Chapter 2 Herpes Simplex Virus Treatment Market: Executive Summary
2.1 Market Summary
Chapter 3 Herpes Simplex Virus Treatment Market: Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing prevalence of herpes infection
3.3.1.2 Development of novel treatment options
3.3.1.3 Increasing government funding
3.3.1.3 Technological advancements
3.3.2 Market Restraint Analysis
3.3.2.1 Unavailability of vaccine
3.4 Porter’s Five Forces Analysis
3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Regulatory Framework
3.7 User Perspective Analysis
Chapter 4 Herpes Simplex Virus Treatment Market: Competitive Landscape
4.1 Recent developments & impact analysis, by key market participants
4.1.1 Ansoff Matrix
4.2 Major deals & strategic alliances analysis
4.2.1 Joint Ventures
4.2.2 Licensing and Partnerships
4.2.3 Technological Collaborations
4.3 Company/Competition Categorization
4.4 Vendor Landscape
4.4.1 List Of Key Distributors and Channel Partners
4.4.2 Key Customers
4.5 Public Companies
4.5.1 Company Market Position Analysis
4.6 Private Companies
4.6.1 List Of Key Emerging Companies
4.6.2 Regional Network Map
Chapter 5 Herpes Simplex Virus Treatment Market: Type Business Analysis
5.1 Definition and Scope
5.2 Type Market Share Analysis, 2023 & 2030
5.3 Global Herpes Simplex Virus Treatment Market, by Type, 2018 To 2030
5.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
5.4.1 Herpes Simplex Virus-1 (HSV-1)
5.4.1.1 Herpes Simplex Virus-1 (HSV-1) Market 2018-2030 (USD Million)
5.4.2 Herpes Simplex Virus-2 (HSV-2)
5.4.2.1 Herpes Simplex Virus-2 (HSV-2) Market, 2018-2030 (USD Million)
Chapter 6 Herpes Simplex Virus Treatment Market: Drug Business Analysis
6.1 Definition and Scope
6.2 Drug Market Share Analysis, 2023 & 2030
6.3 Global Herpes Simplex Virus Treatment Market, by Drug, 2018 To 2030
6.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
6.4.1 Acyclovir
6.4.1.1 Acyclovir Market 2018-2030 (USD Million)
6.4.2 Valacyclovir
6.4.2.1 Valacyclovir Market, 2018-2030 (USD Million)
6.4.3 Famciclovir
6.4.3.1 Famciclovir Market, 2018-2030 (USD Million)
6.4.4 Other Drugs
6.4.4.1 Other Drugs Market, 2018-2030 (USD Million)
Chapter 7 Herpes Simplex Virus Treatment Market: Vaccine Business Analysis
7.1 Definition and Scope
7.2 Vaccine Market Share Analysis, 2023 & 2030
7.3 Global Herpes Simplex Virus Treatment Market, by Vaccine, 2018 To 2030
7.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
7.4.1 Simplirix
7.4.1.1 Simplirix Market 2018-2030 (USD Million)
7.4.2 Others
7.4.2.1 Others Market, 2018-2030 (USD Million)
Chapter 8 Herpes Simplex Virus Treatment Market: Route of Administration Business Analysis
8.1 Definition and Scope
8.2 Route of Administration Market Share Analysis, 2023 & 2030
8.3 Global Herpes Simplex Virus Treatment Market, by Route of Administration, 2018 To 2030
8.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
8.4.1 Oral
8.4.1.1 Oral Market 2018-2030 (USD Million)
8.4.2 Injectable
8.4.2.1 Injectable Market, 2018-2030 (USD Million)
8.4.3 Topical
8.4.3.1 Topical Market, 2018-2030 (USD Million)
Chapter 9 Herpes Simplex Virus Treatment Market: End-use Business Analysis
9.1 Definition and Scope
9.2 End-use Market Share Analysis, 2023 & 2030
9.3 Global Herpes Simplex Virus Treatment Market, by End-use, 2018 To 2030
9.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
9.4.1 Hospital Pharmacy
9.4.1.1 Hospital Pharmacy Market 2018-2030 (USD Million)
9.4.2 Retail Pharmacy
9.4.2.1 Retail Pharmacy Market, 2018-2030 (USD Million)
9.4.3 Online Pharmacy
9.4.3.1 Online Pharmacy Market, 2018-2030 (USD Million)
Chapter 10 Herpes Simplex Virus Treatment Market: Regional Business Analysis
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2023 & 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
10.5.1 North America
10.5.2 Europe
10.5.3 Asia-Pacific
10.5.4 Latin America
10.5.5 MEA
10.6 Market Size, & Forecasts, Trends Analysis, 2023 to 2030
10.7 North America
10.7.1 North America Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.7.2 U.S.
10.7.2.1 U.S. Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.7.3 Canada
10.7.3.1 Canada Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.8 Europe
10.8.1 Europe Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.8.2 UK
10.8.2.1 UK Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.8.3 Germany
10.8.3.1 Germany Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.8.4 France
10.8.4.1 France Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.8.5 Italy
10.8.5.1 Italy Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.8.6 Spain
10.8.6.1 Spain Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.8.7 Denmark
10.8.7.1 Denmark Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.8.8 Sweden
10.8.8.1 Sweden Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.8.9 Norway
10.8.9.1 Norway Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.9 Asia-Pacific
10.9.1 Asia-Pacific Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.9.2 Japan
10.9.2.1 Japan Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.9.3 China
10.9.3.1 China Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.9.4 India
10.9.4.1 India Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.9.5 Australia
10.9.5.1 Australia Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.9.6 South Korea
10.9.6.1 South Korea Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.9.7 Thailand
10.9.7.1 Thailand Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.10 Latin America
10.10.1 Latin America Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.10.2 Brazil
10.10.2.1 Brazil Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.10.3 Mexico
10.10.3.1 Mexico Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.10.4 Argentina
10.10.4.1 Argentina Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.11 MEA
10.11.1 MEA Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.11.2 South Africa
10.11.2.1 South Africa Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.11.3 Saudi Arabia
10.11.3.1 Saudi Arabia Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.11.4 UAE
10.11.4.1 UAE Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
10.11.5 Kuwait
10.11.5.1 Kuwait Herpes Simplex Virus Treatment Market, 2018-2030 (USD Million)
Chapter 11 Herpes Simplex Virus Treatment Market: Company Profiling
11.1 Company Profiles
11.1.1. GSK plc
11.1.1.1 Company Overview
11.1.1.2 Financial Performance
11.1.1.3 Product Benchmarking
11.1.1.4 Strategic Initiatives
11.1.2. Carlsbad Tech
11.1.2.1 Company Overview
11.1.2.2 Financial Performance
11.1.2.3 Product Benchmarking
11.1.2.4 Strategic Initiatives
11.1.3. Emcure Pharmaceuticals Ltd.,
11.1.3.1 Company Overview
11.1.3.2 Financial Performance
11.1.3.3 Product Benchmarking
11.1.3.4 Strategic Initiatives
11.1.4. Sanofi
11.1.4.1 Company Overview
11.1.4.2 Financial Performance
11.1.4.3 Product Benchmarking
11.1.4.4 Strategic Initiatives
11.1.5. Glenmark Pharmaceuticals Inc.
11.1.5.1 Company Overview
11.1.5.2 Financial Performance
11.1.5.3 Product Benchmarking
11.1.5.4 Strategic Initiatives
11.1.6. Fresenius Kabi AG
11.1.6.1 Company Overview
11.1.6.2 Financial Performance
11.1.6.3 Product Benchmarking
11.1.6.4 Strategic Initiatives
11.1.7. Apotex Inc.
11.1.7.1 Company Overview
11.1.7.2 Financial Performance
11.1.7.3 Product Benchmarking
11.1.7.4 Strategic Initiatives
11.1.8. Viatris Inc. (Mylan)
11.1.8.1 Company Overview
11.1.8.2 Financial Performance
11.1.8.3 Product Benchmarking
11.1.8.4 Strategic Initiatives
11.1.9 Teva Pharmaceuticals Industries Ltd.
11.1.11.1 Company Overview
11.1.9.2 Financial Performance
11.1.9.3 Product Benchmarking
11.1.9.4 Strategic Initiatives
List of Tables
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Herpes Simplex Virus Treatment Market, By Region, 2018-2030 (USD Million)
TABLE 5 Global Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 6 Global Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 7 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 8 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 9 Global Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 10 North America Herpes Simplex Virus Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 11 North America Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 12 North America Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 13 North America Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 14 North America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 15 North America Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 16 U.S. Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 17 U.S. Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 18 U.S. Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 19 U.S. Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 20 U.S. Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 21 Canada Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 22 Canada Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 23 Canada Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 24 Canada Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 25 Canada Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 26 Europe Herpes Simplex Virus Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 27 Europe Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 28 Europe Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 29 Europe Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 30 Europe Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 31 Europe Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 32 UK Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 33 UK Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 34 UK Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 35 UK Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 36 UK Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 37 Germany Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 38 Germany Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 39 Germany Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 40 Germany Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 41 Germany Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 42 France Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 43 France Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 44 France Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 45 France Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 46 France Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 47 Spain Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 48 Spain Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 49 Spain Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 50 Spain Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 51 Spain Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 52 Italy Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 53 Italy Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 54 Italy Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 55 Italy Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 56 Italy Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 57 Denmark Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 58 Denmark Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 59 Denmark Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 60 Denmark Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 61 Denmark Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 62 Sweden Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 63 Sweden Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 64 Sweden Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 65 Sweden Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 66 Sweden Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 67 Norway Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 68 Norway Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 69 Norway Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 70 Norway Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 71 Norway Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 72 Asia-Pacific Herpes Simplex Virus Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 73 Asia-Pacific Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 74 Asia-Pacific Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 75 Asia-Pacific Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 76 Asia-Pacific Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 77 Asia-Pacific Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 78 China Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 79 China Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 80 China Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 81 China Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 82 China Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 83 Japan Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 84 Japan Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 85 Japan Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 86 Japan Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 87 Japan Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 88 India Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 89 India Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 90 India Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 91 India Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 92 India Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 93 South Korea Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 94 South Korea Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 95 South Korea Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 96 South Korea Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 97 South Korea Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 98 Australia Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 99 Australia Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 100 Australia Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 101 Australia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 102 Australia Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 103 Thailand Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 104 Thailand Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 105 Thailand Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 106 Thailand Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 107 Thailand Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 108 Latin America Herpes Simplex Virus Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 109 Latin America Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 110 Latin America Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 111 Latin America Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 112 Latin America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 113 Latin America Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 114 Brazil Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 115 Brazil Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 116 Brazil Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 117 Brazil Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 118 Brazil Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 119 Mexico Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 120 Mexico Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 121 Mexico Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 122 Mexico Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 123 Mexico Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 124 Argentina Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 125 Argentina Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 126 Argentina Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 127 Argentina Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 128 Argentina Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 129 MEA Herpes Simplex Virus Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 130 MEA Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 131 MEA Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 132 MEA Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 133 MEA Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 134 MEA Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 135 South Africa Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 136 South Africa Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 137 South Africa Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 138 South Africa Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 139 South Africa Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 140 Saudi Arabia Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 141 Saudi Arabia Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 142 Saudi Arabia Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 143 Saudi Arabia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 144 Saudi Arabia Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 145 UAE Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 146 UAE Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 147 UAE Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 148 UAE Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 149 UAE Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
TABLE 150 Kuwait Herpes Simplex Virus Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 151 Kuwait Herpes Simplex Virus Treatment Market, By Drug, 2018-2030 (USD Million)
TABLE 152 Kuwait Herpes Simplex Virus Treatment Market, By Vaccine, 2018-2030 (USD Million)
TABLE 153 Kuwait Herpes Simplex Virus Treatment Market, By Route of Administration, 2018-2030 (USD Million)
TABLE 154 Kuwait Herpes Simplex Virus Treatment Market, By End-use, 2018-2030 (USD Million)
List of Figures
FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Herpes Simplex Virus Treatment Market Segmentation
FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 11 Penetration & Growth Prospect Mapping
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Market Penetration & Growth Prospect Mapping
FIG. 15 Herpes Simplex Virus Treatment Market: Treatment Movement Analysis
FIG. 16 Herpes Simplex Virus-1 (HSV-1)market, 2018-2030 (USD Million)
FIG. 17 Herpes simplex virus-2 (HSV-2)market, 2018-2030 (USD Million)
FIG. 18 Herpes Simplex Virus Treatment Market: Drug Movement Analysis
FIG. 19 Acyclovir market, 2018-2030 (USD Million)
FIG. 20 Valacyclovir market, 2018-2030 (USD Million)
FIG. 21 Famciclovir market, 2018-2030 (USD Million)
FIG. 22 Others drugs market, 2018-2030 (USD Million)
FIG. 23 Herpes Simplex Virus Treatment Market: Vaccine Movement Analysis
FIG. 24 Herpes Simplex Virus Treatment Market: Route of Administration Movement Analysis
FIG. 25 Oral market, 2018-2030 (USD Million)
FIG. 26 Injectable market, 2018-2030 (USD Million)
FIG. 27 Topical market, 2018-2030 (USD Million)
FIG. 28 Herpes Simplex Virus Treatment Market: End-use Movement Analysis
FIG. 29 Hospital pharmacy market, 2018-2030 (USD Million)
FIG. 30 Retail pharmacy market, 2018-2030 (USD Million)
FIG. 31 Online pharmacy market, 2018-2030 (USD Million)
FIG. 32 Regional Marketplace: Key Takeaways
FIG. 33 Regional Outlook, 2018 & 2030
FIG. 34 Regional Market Dashboard
FIG. 35 Regional Market Place: Key Takeaways
FIG. 36 North America, SWOT Analysis
FIG. 37 Europe, SWOT Analysis
FIG. 38 Asia-Pacific, SWOT Analysis
FIG. 39 Latin America, SWOT Analysis
FIG. 40 MEA, SWOT Analysis
FIG. 41 North America
FIG. 42 North America Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 43 U.S. Key Country Dynamics
FIG. 44 U.S. Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 45 Canada Key Country Dynamics
FIG. 46 Canada Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 47 Europe
FIG. 48 Europe Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 49 UK Key Country Dynamics
FIG. 50 UK Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 51 Germany Key Country Dynamics
FIG. 52 Germany Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 53 France Key Country Dynamics
FIG. 54 France Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 55 Italy Key Country Dynamics
FIG. 56 Italy Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 57 Spain Key Country Dynamics
FIG. 58 Spain Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 59 Denmark Key Country Dynamics
FIG. 60 Denmark Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 61 Sweden Key Country Dynamics
FIG. 62 Sweden Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 63 Norway Key Country Dynamics
FIG. 64 Norway Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 65 Asia-Pacific
FIG. 66 Asia-Pacific Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 67 Japan Key Country Dynamics
FIG. 68 Japan Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 69 China Key Country Dynamics
FIG. 70 China Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 71 India Key Country Dynamics
FIG. 72 India Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 73 Australia Key Country Dynamics
FIG. 74 Australia Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 75 South Korea Key Country Dynamics
FIG. 76 South Korea Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 77 Thailand Key Country Dynamics
FIG. 78 Thailand Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 79 Latin America
FIG. 80 Latin America Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 81 Brazil Key Country Dynamics
FIG. 82 Brazil Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 83 Mexico Key Country Dynamics
FIG. 84 Mexico Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 85 Argentina Key Country Dynamics
FIG. 86 Argentina Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 87 MEA
FIG. 88 MEA Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 89 South Africa Key Country Dynamics
FIG. 90 South Africa Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 91 Saudi Arabia Key Country Dynamics
FIG. 92 Saudi Arabia Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 93 UAE Key Country Dynamics
FIG. 94 UAE Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 95 Kuwait Key Country Dynamics
FIG. 96 Kuwait Market Estimates And Forecasts, 2018-2030 (USD Million)
FIG. 97 Strategy Mapping

Companies Mentioned

  • GSK plc
  • Carlsbad Tech
  • Emcure Pharmaceuticals Ltd.,
  • Sanofi
  • Glenmark Pharmaceuticals Inc.
  • Fresenius Kabi AG
  • Apotex Inc.
  • Viatris Inc. (Mylan)
  • Teva Pharmaceuticals Industries Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Herpes Simplex Virus Treatment Global Market Report 2024 - Product Image

Herpes Simplex Virus Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Herpes Simplex Virus Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018 - 2028 Segmented by Virus Type, By Treatment, By Route of Administration, By Distribution Channel, By Region - Product Image

Herpes Simplex Virus Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018 - 2028 Segmented by Virus Type, By Treatment, By Route of Administration, By Distribution Channel, By Region

  • Report
  • 113 Pages
  • Global
From
Herpes Simplex Virus Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Herpes Simplex Virus Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 108 Pages
  • Global
From
Herpes Simplex Virus Treatment Market - Forecasts from 2024 to 2029 - Product Image

Herpes Simplex Virus Treatment Market - Forecasts from 2024 to 2029

  • Report
  • 140 Pages
  • Global
From
Herpes Simplex Virus Treatment Market by Type, Drug type, Distribution channel, and Geography: Forecast up to 2027 - Product Image

Herpes Simplex Virus Treatment Market by Type, Drug type, Distribution channel, and Geography: Forecast up to 2027

  • Report
  • 321 Pages
  • Global
From

About the Herpes Drug Market

The Herpes Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of infectious diseases. Herpes drugs are used to treat the herpes simplex virus (HSV) and its associated conditions, such as genital herpes, cold sores, and shingles. These drugs can be administered orally, topically, or intravenously, depending on the severity of the infection. Commonly prescribed herpes drugs include acyclovir, valacyclovir, and famciclovir. Herpes drugs are typically prescribed for short-term use, as the virus is incurable. However, these drugs can help reduce the severity and duration of symptoms, as well as reduce the risk of transmission. As such, they are an important part of managing the virus. Some companies in the Herpes Drug market include GlaxoSmithKline, Merck, Pfizer, and Novartis. These companies produce a variety of herpes drugs, including acyclovir, valacyclovir, and famciclovir. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.